{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T11:38:55Z","timestamp":1794310735184,"version":"4.9.0"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"44","license":[{"start":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:00:00Z","timestamp":1761868800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,10,31]]},"abstract":"<jats:sec>\n                    <jats:title>Rationale:<\/jats:title>\n                    <jats:p>Drug-induced immune hemolytic anemia is a rare but serious cause of autoimmune hemolytic anemia, most frequently triggered by antimicrobials. Vancomycin is an exceedingly rare culprit, with only a handful of cases reported.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patient concerns:<\/jats:title>\n                    <jats:p>A 64-year-old woman developed acute-onset fever, tachycardia, dyspnea, and dark-colored urine on the 7th day after revision knee arthroplasty, during which she was receiving intravenous vancomycin prophylaxis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Diagnoses:<\/jats:title>\n                    <jats:p>Laboratory findings revealed a dramatic drop in hemoglobin, indirect hyperbilirubinemia, elevated lactate dehydrogenase, and reticulocytosis, consistent with hemolysis. The direct antiglobulin test was positive for IgG and C3, confirming immune-mediated hemolysis. A comprehensive workup ruled out infections, autoimmune diseases, and malignancies. The association with vancomycin was categorized as \u201cprobable\u201d on the Naranjo scale.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions:<\/jats:title>\n                    <jats:p>Vancomycin was immediately discontinued. The patient received intravenous methylprednisolone and immunoglobulins. Due to rapid progression to life-threatening anemia and hemodynamic instability, therapeutic plasma exchange and washed red blood cell transfusions were initiated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcomes:<\/jats:title>\n                    <jats:p>Following these interventions, the patient\u2019s condition gradually stabilized. Hemoglobin levels improved, hemolytic markers normalized, and she was successfully weaned from mechanical ventilation. She was discharged after 1 month on a prolonged steroid taper, with a full hematologic recovery observed on follow-up.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Lessons:<\/jats:title>\n                    <jats:p>Vancomycin can induce life-threatening immune hemolytic anemia. Clinicians must maintain a high index of suspicion for drug-induced immune hemolytic anemia in patients with abrupt hemolysis after initiating a new drug, as immediate discontinuation of the offending agent is the cornerstone of management.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000045544","type":"journal-article","created":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T17:01:59Z","timestamp":1763571719000},"page":"e45544","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Life-threatening vancomycin-induced immune hemolytic anemia: A rare case report"],"prefix":"10.1097","volume":"104","author":[{"given":"Jiang-Chen","family":"Peng","sequence":"first","affiliation":[{"name":"Department of Critical Care, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3777-140X","authenticated-orcid":false,"given":"Yuan","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Critical Care, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260520","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1182\/asheducation-2018.1.382","article-title":"Autoimmune hemolytic anemia.","volume":"2018","author":"Hill","year":"2018","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"R2-20260520","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/bjh.14654","article-title":"Guidelines on the management of drug-induced immune and secondary autoimmune, haemolytic anaemia.","volume":"177","author":"Hill","year":"2017","journal-title":"Br J Haematol"},{"key":"R3-20260520","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1182\/asheducation-2009.1.73","article-title":"Drug-induced immune hemolytic anemia.","volume":"1","author":"Garratty","year":"2009","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"R4-20260520","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1182\/bloodadvances.2023009801","article-title":"Drug-induced immune hemolytic anemia: detection of new signals and risk assessment in a nationwide cohort study.","volume":"8","author":"Maquet","year":"2024","journal-title":"Blood Adv"},{"key":"R5-20260520","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/j.1365-2141.2011.08784.x","article-title":"Drug induced immune haemolytic anaemia in the Berlin case\u2013control surveillance study.","volume":"154","author":"Garbe","year":"2011","journal-title":"Br J Haematol"},{"key":"R6-20260520","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions.","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther"},{"key":"R7-20260520","doi-asserted-by":"crossref","first-page":"100648","DOI":"10.1016\/j.blre.2019.100648","article-title":"Diagnosis and treatment of autoimmune hemolytic anemia in adults: recommendations from the First International Consensus Meeting.","volume":"41","author":"J\u00e4ger","year":"2020","journal-title":"Blood Rev"},{"key":"R8-20260520","doi-asserted-by":"crossref","first-page":"66","DOI":"10.21307\/immunohematology-2019-100","article-title":"Drugs that have been shown to cause drug-induced immune hemolytic anemia or positive direct antiglobulin tests: some interesting findings since 2007.","volume":"30","author":"Garratty","year":"2014","journal-title":"Immunohematology"},{"key":"R9-20260520","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.blre.2010.06.004","article-title":"Immune hemolytic anemia associated with drug therapy.","volume":"24","author":"Garratty","year":"2010","journal-title":"Blood Rev"},{"key":"R10-20260520","doi-asserted-by":"crossref","first-page":"44","DOI":"10.21307\/immunohematology-2019-098","article-title":"Drug-induced immune hemolytic anemia: the last 30 years of changes.","volume":"30","author":"Arndt","year":"2014","journal-title":"Immunohematology"},{"key":"R11-20260520","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1309\/AJCPBVLJZH6W6RQM","article-title":"Pathology consultation on drug-induced hemolytic anemia.","volume":"136","author":"Pierce","year":"2011","journal-title":"Am J Clin Pathol"},{"key":"R12-20260520","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1056\/NEJMoa065066","article-title":"Vancomycin-induced immune thrombocytopenia.","volume":"356","author":"Von Drygalski","year":"2007","journal-title":"N Engl J Med"},{"key":"R13-20260520","first-page":"1","article-title":"Vancomycin-induced DRESS syndrome: a systematic review of case reports.","author":"Bhumireddy","year":"2025","journal-title":"Hosp Pharm"},{"key":"R14-20260520","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/trf.14362","article-title":"Drug-induced immune hemolytic anemia associated with anti-vancomycin complicated by a paraben antibody.","volume":"58","author":"Gniadek","year":"2018","journal-title":"Transfusion"},{"key":"R15-20260520","first-page":"e5848","article-title":"Vancomycin spacer-induced hemolysis.","volume":"11","author":"Sudhakaran","year":"2019","journal-title":"Cureus"},{"key":"R16-20260520","first-page":"e39191","article-title":"Vancomycin-induced hemolytic anemia.","volume":"15","author":"Siddiqui","year":"2023","journal-title":"Cureus"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000045544","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T11:04:24Z","timestamp":1779275064000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000045544"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,31]]},"references-count":16,"journal-issue":{"issue":"44","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000045544","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,31]]},"assertion":[{"value":"2025-07-24","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-03","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}